Sun Pharmaceutical Industries has struck its largest global deal to acquire US-based Organon for $11.75 billion. This deal expands Sun Pharma's footprint to 150 markets. Will it pay off?
This edition also carries Nachiket Kelkar’s deep dive on the Gujarat International Finance Tec-City, or GIFT City, which is taking shape as a cross-border finance hub.